CLINOVEX – Clinical Research Solutions located in cochin, India is a premier Research & Training institute in clinical & biomedical sciences providing high quality, innovative approach to both Research & Training.
M.sandhya sree*, Sowmya**
*Assistant Professor ,
Department of pharmacology,
BA&KR pharmacy college,
JNTUK, Andhra Pradesh.
Guntur, Andhra Pradesh.
The study was conducted in two villages of Guntur district (Andra Pradesh) to determine the nature and extent of health problems of rural women. The data were collected from one hundred randomly selected rural ladies by interviewing them with the help of an interview schedule developed for the purpose.
The identified health problems were classified. The findings of the study indicated the prevalence of a number of health problems among rural women and a need was felt for their education on health aspects. A sizeable number of them were found to have suffered from bronchitis, coryza, indigestion, constipation, diarrhea , conjunctivitis, dandruff, tartar deposits on teeth, skin diseases, gynecological diseases and some other diseases like rheumatism, arthritis, etc.
The existence of a government hospital in village had no association of significant level with the health problems of rural women. Majority of the respondents perceived the treatment given in government hospital to be not effective and several other constraints in availing of the treatment facilities.
Rajendra Memorial Research Institute of Medical Sciences, Patna, a permanent Institute under Indian Council of Medical Research, Dept. of Health Research, Ministry of Health & Family Welfare, Govt. of India, invites applications from suitable Indian Nationals for appointment on the following posts:
Natural Remedies, a pioneer in phytopharmaceuticals is today credited with integrating scientific approach to search medicines and health supplements ensuring purity, safety and affordability.
At Apollo Health Street, we have a strong tradition and belief that personal satisfaction comes from playing an integral part in an organization. In short, we believe in empowered associates. That’s why we are always looking to build our team of healthcare experts who are uniquely passionate about helping healthcare organizations achieve their True Return.
Recognising the high incidence of tuberculosis around Dharmasthala, a modern TB Sanatorium was established at Laila under the aegis of the Shri Dharmasthala Manjunatheshwara Medical Trust. Now it has been turned into a general hospital since April 2003 as private institutions are not allowed to treat tuberculosis patients.
Indegene's scientific and competitive intelligence services lend actionable insights to clients to support their strategic decision making. We provide scientific, clinical, and competitive insights to help align the business development, licensing, clinical development, and marketing activities of our clients to current and future market needs.
The setting up of a separate Department of Biotechnology (DBT), under the Ministry of Science and Technology in 1986 gave a new impetus to the development of the field of modern biology and biotechnology in India. In more than a decade of its existence, the department has promoted and accelerated the pace of development of biotechnology in the country. Through several R&D projects, demonstrations and creation of infrastructural facilities a clear visible impact of this field has been seen.
SIRO Clinpharm is one of the leading Global Clinical Research Organizations (CROs), offering full scope services conducting clinical trials in the Pharmaceutical, Biotechnology and Medical Devices sectors in compliance with International Standards. We are headquartered in India having global presence in USA, Israel and in Europe at Germany, Czech Republic, Greece, Estonia, Romania, Spain and France.
Columbia Asia is a consortium of healthcare companies operating across the Asian continent, with hospitals in India, Malaysia, Vietnam and Indonesia. There are 16 Columbia Asia facilities in operation and 17 new hospitals set to open by the end of 2011. Most of the growth will be in the company's largest market - India.